nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—S100A13—epithelium—cervical cancer	0.026	0.0601	CbGeAlD
Amlexanox—S100A12—epithelium—cervical cancer	0.0256	0.0593	CbGeAlD
Amlexanox—S100A12—uterine cervix—cervical cancer	0.0254	0.0588	CbGeAlD
Amlexanox—S100A12—decidua—cervical cancer	0.0242	0.0561	CbGeAlD
Amlexanox—S100A13—renal system—cervical cancer	0.0241	0.0558	CbGeAlD
Amlexanox—IL3—lymph node—cervical cancer	0.0238	0.0551	CbGeAlD
Amlexanox—S100A12—mammalian vulva—cervical cancer	0.0222	0.0515	CbGeAlD
Amlexanox—S100A13—female reproductive system—cervical cancer	0.0193	0.0447	CbGeAlD
Amlexanox—S100A13—female gonad—cervical cancer	0.0176	0.0407	CbGeAlD
Amlexanox—S100A12—female gonad—cervical cancer	0.0173	0.0401	CbGeAlD
Amlexanox—S100A12—vagina—cervical cancer	0.0172	0.0399	CbGeAlD
Amlexanox—FGF1—epithelium—cervical cancer	0.016	0.037	CbGeAlD
Amlexanox—FGF1—renal system—cervical cancer	0.0148	0.0343	CbGeAlD
Amlexanox—PDE4A—decidua—cervical cancer	0.0143	0.0331	CbGeAlD
Amlexanox—FGF1—female reproductive system—cervical cancer	0.0119	0.0275	CbGeAlD
Amlexanox—PDE4D—female gonad—cervical cancer	0.0116	0.0268	CbGeAlD
Amlexanox—S100A13—lymph node—cervical cancer	0.0113	0.0261	CbGeAlD
Amlexanox—S100A12—lymph node—cervical cancer	0.0111	0.0258	CbGeAlD
Amlexanox—FGF1—female gonad—cervical cancer	0.0108	0.025	CbGeAlD
Amlexanox—PDE4A—female gonad—cervical cancer	0.0102	0.0237	CbGeAlD
Amlexanox—PDE4B—uterine cervix—cervical cancer	0.00894	0.0207	CbGeAlD
Amlexanox—PDE4B—decidua—cervical cancer	0.00852	0.0197	CbGeAlD
Amlexanox—PDE4B—endometrium—cervical cancer	0.00809	0.0187	CbGeAlD
Amlexanox—PDE4B—mammalian vulva—cervical cancer	0.00782	0.0181	CbGeAlD
Amlexanox—PDE4D—lymph node—cervical cancer	0.00743	0.0172	CbGeAlD
Amlexanox—FGF1—lymph node—cervical cancer	0.00695	0.0161	CbGeAlD
Amlexanox—PDE4B—female reproductive system—cervical cancer	0.0067	0.0155	CbGeAlD
Amlexanox—PDE4A—lymph node—cervical cancer	0.00657	0.0152	CbGeAlD
Amlexanox—PDE4B—female gonad—cervical cancer	0.0061	0.0141	CbGeAlD
Amlexanox—PDE4B—vagina—cervical cancer	0.00606	0.014	CbGeAlD
Amlexanox—PDE4B—lymph node—cervical cancer	0.00392	0.00908	CbGeAlD
Amlexanox—PDE4D—Signaling by GPCR—TAAR6—cervical cancer	0.00141	0.00248	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—MTOR—cervical cancer	0.0014	0.00246	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—FGFR3—cervical cancer	0.00138	0.00242	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—FGFR3—cervical cancer	0.00137	0.00241	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TAAR6—cervical cancer	0.00136	0.0024	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—MTOR—cervical cancer	0.00136	0.0024	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—FGFR3—cervical cancer	0.00136	0.0024	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—FGFR3—cervical cancer	0.00136	0.00239	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TAAR6—cervical cancer	0.00134	0.00236	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—UBE3A—cervical cancer	0.00134	0.00236	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cervical cancer	0.00134	0.00235	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.0013	0.00228	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—FGFR3—cervical cancer	0.00128	0.00225	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—FGFR3—cervical cancer	0.00128	0.00225	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—FGFR3—cervical cancer	0.00128	0.00225	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—FGFR3—cervical cancer	0.00127	0.00223	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—WNT2—cervical cancer	0.00126	0.00222	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—MTOR—cervical cancer	0.00126	0.00222	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—FGFR3—cervical cancer	0.00125	0.00221	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—FGFR3—cervical cancer	0.00125	0.0022	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TAAR6—cervical cancer	0.00124	0.00218	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKAP13—cervical cancer	0.00122	0.00215	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—FGFR3—cervical cancer	0.00118	0.00208	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—WNT2—cervical cancer	0.00116	0.00205	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.00113	0.00199	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—cervical cancer	0.00112	0.00198	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKAP13—cervical cancer	0.00111	0.00195	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—WNT2—cervical cancer	0.0011	0.00193	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.00109	0.00192	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—MTOR—cervical cancer	0.00108	0.0019	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKAP13—cervical cancer	0.00106	0.00187	CbGpPWpGaD
Amlexanox—IL3—Immune System—HLA-DPB1—cervical cancer	0.00106	0.00186	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.00105	0.00185	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—WNT2—cervical cancer	0.00105	0.00184	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—MTOR—cervical cancer	0.00103	0.00181	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00103	0.00181	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKAP13—cervical cancer	0.00102	0.0018	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—MTOR—cervical cancer	0.00101	0.00179	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—EGFR—cervical cancer	0.00101	0.00178	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKAP13—cervical cancer	0.00101	0.00178	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—EGFR—cervical cancer	0.000989	0.00174	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—EGFR—cervical cancer	0.000981	0.00173	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—MTOR—cervical cancer	0.000969	0.00171	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—WNT2—cervical cancer	0.000967	0.0017	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—MTOR—cervical cancer	0.000964	0.0017	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKAP13—cervical cancer	0.000964	0.0017	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—MTOR—cervical cancer	0.00096	0.00169	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—cervical cancer	0.000958	0.00169	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—WNT5A—cervical cancer	0.000956	0.00168	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—MTOR—cervical cancer	0.000955	0.00168	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TAAR6—cervical cancer	0.000955	0.00168	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	0.000941	0.00166	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKAP13—cervical cancer	0.000935	0.00165	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKAP13—cervical cancer	0.000918	0.00162	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	0.000898	0.00158	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—MTOR—cervical cancer	0.000898	0.00158	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—MTOR—cervical cancer	0.000898	0.00158	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—MTOR—cervical cancer	0.00089	0.00157	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.000883	0.00155	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—WNT5A—cervical cancer	0.000882	0.00155	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—MTOR—cervical cancer	0.000879	0.00155	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGFR3—cervical cancer	0.00087	0.00153	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGFR3—cervical cancer	0.000868	0.00153	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKAP13—cervical cancer	0.000849	0.00149	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HLA-DPB1—cervical cancer	0.000848	0.00149	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—STAT3—cervical cancer	0.000833	0.00147	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—WNT5A—cervical cancer	0.000832	0.00146	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—MTOR—cervical cancer	0.000831	0.00146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TAAR6—cervical cancer	0.000831	0.00146	CbGpPWpGaD
Amlexanox—IL3—Immune System—HLA-DQB1—cervical cancer	0.000826	0.00145	CbGpPWpGaD
Amlexanox—FGF1—Immune System—UBE3A—cervical cancer	0.000812	0.00143	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HLA-DPB1—cervical cancer	0.000799	0.00141	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000796	0.0014	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—WNT5A—cervical cancer	0.000792	0.00139	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TAAR6—cervical cancer	0.000791	0.00139	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000778	0.00137	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD8A—cervical cancer	0.000771	0.00136	CbGpPWpGaD
Amlexanox—FGF1—Disease—WNT2—cervical cancer	0.000761	0.00134	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—EGFR—cervical cancer	0.000757	0.00133	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00075	0.00132	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—STAT3—cervical cancer	0.000749	0.00132	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—WNT2—cervical cancer	0.000745	0.00131	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CASP8—cervical cancer	0.000742	0.00131	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—WNT5A—cervical cancer	0.000733	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TAAR6—cervical cancer	0.000732	0.00129	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000724	0.00127	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.000724	0.00127	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—EGFR—cervical cancer	0.000713	0.00125	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—STAT3—cervical cancer	0.000694	0.00122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TAAR6—cervical cancer	0.000683	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—EGFR—cervical cancer	0.000681	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—STAT3—cervical cancer	0.000679	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—EGFR—cervical cancer	0.000677	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—EGFR—cervical cancer	0.000674	0.00119	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—EGFR—cervical cancer	0.000671	0.00118	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HLA-DQB1—cervical cancer	0.000662	0.00117	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—cervical cancer	0.000661	0.00116	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKAP13—cervical cancer	0.000654	0.00115	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—WNT2—cervical cancer	0.000649	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—EGFR—cervical cancer	0.000631	0.00111	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—EGFR—cervical cancer	0.000631	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000631	0.00111	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGFR3—cervical cancer	0.000631	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—EGFR—cervical cancer	0.000625	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000624	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.00062	0.00109	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOTCH2—cervical cancer	0.000619	0.00109	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD8A—cervical cancer	0.000618	0.00109	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—WNT2—cervical cancer	0.000618	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—EGFR—cervical cancer	0.000617	0.00109	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000615	0.00108	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—MTOR—cervical cancer	0.000612	0.00108	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—MTOR—cervical cancer	0.000611	0.00107	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD4—cervical cancer	0.00061	0.00107	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000594	0.00104	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—EGFR—cervical cancer	0.000584	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD8A—cervical cancer	0.000583	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Disease—WNT5A—cervical cancer	0.000577	0.00101	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—WNT2—cervical cancer	0.000571	0.00101	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKAP13—cervical cancer	0.00057	0.001	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—WNT5A—cervical cancer	0.000565	0.000994	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CASP3—cervical cancer	0.000563	0.000991	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000559	0.000984	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKAP13—cervical cancer	0.000542	0.000954	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CTNNB1—cervical cancer	0.000542	0.000953	CbGpPWpGaD
Amlexanox—IL3—Immune System—CASP8—cervical cancer	0.00054	0.00095	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—WNT2—cervical cancer	0.000533	0.000938	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HES1—cervical cancer	0.000507	0.000893	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGFR3—cervical cancer	0.000506	0.00089	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKAP13—cervical cancer	0.000502	0.000883	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—cervical cancer	0.000499	0.000879	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000499	0.000877	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGFR3—cervical cancer	0.000496	0.000873	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—WNT5A—cervical cancer	0.000492	0.000865	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DPB1—cervical cancer	0.000485	0.000853	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGFR3—cervical cancer	0.000477	0.000839	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—STAT3—cervical cancer	0.000473	0.000832	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—WNT5A—cervical cancer	0.000468	0.000824	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKAP13—cervical cancer	0.000468	0.000823	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TERT—cervical cancer	0.000445	0.000782	CbGpPWpGaD
Amlexanox—IL3—Immune System—MTOR—cervical cancer	0.000444	0.000781	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—cervical cancer	0.000443	0.00078	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—WNT5A—cervical cancer	0.000433	0.000762	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CASP8—cervical cancer	0.000432	0.000761	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—EGFR—cervical cancer	0.00043	0.000757	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EGFR—cervical cancer	0.000429	0.000755	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CASP8—cervical cancer	0.000424	0.000747	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGFR3—cervical cancer	0.000408	0.000718	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—WNT5A—cervical cancer	0.000404	0.000711	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOTCH2—cervical cancer	0.000396	0.000698	CbGpPWpGaD
Amlexanox—IL3—Immune System—CTNNB1—cervical cancer	0.000394	0.000693	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOTCH1—cervical cancer	0.000383	0.000674	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DQB1—cervical cancer	0.000378	0.000666	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MTOR—cervical cancer	0.000356	0.000626	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—cervical cancer	0.000355	0.000625	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD8A—cervical cancer	0.000353	0.000622	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MTOR—cervical cancer	0.000349	0.000614	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—cervical cancer	0.000348	0.000613	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOTCH2—cervical cancer	0.000345	0.000607	CbGpPWpGaD
Amlexanox—IL3—Immune System—STAT3—cervical cancer	0.000343	0.000604	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EGFR—cervical cancer	0.000341	0.000601	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—MTOR—cervical cancer	0.000335	0.00059	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—cervical cancer	0.000335	0.000589	CbGpPWpGaD
Amlexanox—FGF1—Disease—HES1—cervical cancer	0.000332	0.000584	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOTCH2—cervical cancer	0.000329	0.000578	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HES1—cervical cancer	0.000325	0.000572	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CTNNB1—cervical cancer	0.000315	0.000555	CbGpPWpGaD
Amlexanox—IL3—Immune System—EGFR—cervical cancer	0.000312	0.000549	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CTNNB1—cervical cancer	0.00031	0.000545	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOTCH2—cervical cancer	0.000304	0.000535	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—cervical cancer	0.000292	0.000513	CbGpPWpGaD
Amlexanox—FGF1—Disease—TERT—cervical cancer	0.000291	0.000512	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGFR3—cervical cancer	0.000289	0.000509	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MTOR—cervical cancer	0.000287	0.000505	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TERT—cervical cancer	0.000285	0.000501	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOTCH2—cervical cancer	0.000283	0.000499	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HES1—cervical cancer	0.000283	0.000498	CbGpPWpGaD
Amlexanox—S100A12—Immune System—STAT3—cervical cancer	0.000275	0.000484	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HES1—cervical cancer	0.000269	0.000474	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGFR3—cervical cancer	0.000267	0.00047	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CASP3—cervical cancer	0.000264	0.000465	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGFR3—cervical cancer	0.000261	0.00046	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CTNNB1—cervical cancer	0.000254	0.000448	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOTCH1—cervical cancer	0.000251	0.000441	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—cervical cancer	0.00025	0.00044	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HES1—cervical cancer	0.000249	0.000439	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TERT—cervical cancer	0.000248	0.000436	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CASP8—cervical cancer	0.000247	0.000435	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOTCH1—cervical cancer	0.000245	0.000432	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—cervical cancer	0.000245	0.000432	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TERT—cervical cancer	0.000236	0.000415	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—cervical cancer	0.000235	0.000414	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HES1—cervical cancer	0.000232	0.000409	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGFR3—cervical cancer	0.000228	0.0004	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—STAT3—cervical cancer	0.000222	0.00039	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—cervical cancer	0.000219	0.000385	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TERT—cervical cancer	0.000218	0.000384	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGFR3—cervical cancer	0.000217	0.000381	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOTCH1—cervical cancer	0.000214	0.000376	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TERT—cervical cancer	0.000204	0.000358	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOTCH1—cervical cancer	0.000203	0.000358	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MTOR—cervical cancer	0.000203	0.000358	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—cervical cancer	0.000203	0.000357	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—cervical cancer	0.000202	0.000355	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGFR3—cervical cancer	0.0002	0.000353	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—cervical cancer	0.00019	0.000335	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOTCH1—cervical cancer	0.000188	0.000331	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTOR—cervical cancer	0.000188	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—cervical cancer	0.000187	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGFR3—cervical cancer	0.000187	0.000329	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MTOR—cervical cancer	0.000184	0.000324	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—cervical cancer	0.000181	0.000319	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTNNB1—cervical cancer	0.00018	0.000317	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOTCH1—cervical cancer	0.000175	0.000309	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—cervical cancer	0.000169	0.000298	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CASP3—cervical cancer	0.000169	0.000298	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—cervical cancer	0.000168	0.000295	CbGpPWpGaD
Amlexanox—FGF1—Disease—CTNNB1—cervical cancer	0.000166	0.000293	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CTNNB1—cervical cancer	0.000163	0.000287	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MTOR—cervical cancer	0.00016	0.000282	CbGpPWpGaD
Amlexanox—FGF1—Immune System—STAT3—cervical cancer	0.000157	0.000277	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MTOR—cervical cancer	0.000152	0.000268	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CASP3—cervical cancer	0.000147	0.000259	CbGpPWpGaD
Amlexanox—FGF1—Disease—STAT3—cervical cancer	0.000145	0.000255	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—cervical cancer	0.000143	0.000251	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—STAT3—cervical cancer	0.000142	0.00025	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CTNNB1—cervical cancer	0.000142	0.00025	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MTOR—cervical cancer	0.000141	0.000248	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CASP3—cervical cancer	0.00014	0.000247	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CTNNB1—cervical cancer	0.000135	0.000238	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—cervical cancer	0.000132	0.000232	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MTOR—cervical cancer	0.000131	0.000231	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CASP3—cervical cancer	0.00013	0.000228	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—cervical cancer	0.000129	0.000227	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CTNNB1—cervical cancer	0.000125	0.00022	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT3—cervical cancer	0.000124	0.000218	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CASP3—cervical cancer	0.000121	0.000213	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT3—cervical cancer	0.000118	0.000207	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CTNNB1—cervical cancer	0.000117	0.000205	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—cervical cancer	0.000112	0.000198	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT3—cervical cancer	0.000109	0.000192	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—cervical cancer	0.000108	0.000191	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—cervical cancer	0.000107	0.000188	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT3—cervical cancer	0.000102	0.000179	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—cervical cancer	9.9e-05	0.000174	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—cervical cancer	9.44e-05	0.000166	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—cervical cancer	9.23e-05	0.000162	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—cervical cancer	8.99e-05	0.000158	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—cervical cancer	8.31e-05	0.000146	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—cervical cancer	7.75e-05	0.000136	CbGpPWpGaD
